WebDec 6, 2006 · We tested the main hypotheses that cisatracurium compared to rocuronium would decrease the following: • the incidence of partial paralysis at end of surgery • the time between skin closure and extubation of the patients' trachea (primary outcome criteria); • the time to recovery of the T4/T1 ratio to 0.9; • WebIn contrast to routinely used atracurium,cisatracurium is comparatively a newer drug with lesser histamine release. The study was designed with the aim to compare the efficacy of atracurium (2×ED95) and cisatracurium (4×ED95).90 patients, 6 months-5 years , ASA class I &II were randomly allocated to cisatracurium and atracurium group.
Incidence of Residual Neuromuscular Blockade in Children Below …
WebIn a separate study of infants and children anesthetized with nitrous oxide and opioids, 0.15 mg/kg (three times the ED 95) of cisatracurium had a mean onset time of maximum … WebApr 7, 2005 · Thirty-seven children from 3 months to 16 years old (median 4.1 year) were randomised to receive either drug; those already receiving more than 6 h of … trevor\u0027s charizard
Considerations in Neuromuscular Blockade in the ICU: A Case ... - Hindawi
Webtransplantation were assigned to group A (21 adults) or group B (21 children affected by congenital biliary atresia). All patients received a 2 fold ED 95 of cisatracurium (0.1 mg/kg) to facilitate the tracheal intubation and neuromus-cular blocking was monitored by train-of-four. An additional dose of cisatracurium (0.03 mg/kg) was given once T1 WebCisatracurium and rocuronium are non-depolarizing muscle relaxants belonging to different classes of intermediate acting muscle relaxants, with cisatracurium belonging to … WebJan 19, 2024 · The daily dose of cisatracurium used in center 1 increased from 150 mg (90–240, day 0) to 300 mg (166–330, day 3) ( p < 0.01 after comparison), and the daily dose of atracurium used in center 2 increased from 219 mg (153–235, day 0) to 362 mg (217–454, day 3) ( p = 0.03 after comparison). Fig. 3 trevor\u0027s vision